ATE502T1 - Salze von zur dauernden bindung an die gallensaeuren faehigen nicht toxischen aktivierten anionenaustauscherharzen mit 2-(4'-(p-chlorbenzoyl)-ph enoxy)-2-(methyl)-propionsaeure und diese salze enthaltende arzneimittel. - Google Patents

Salze von zur dauernden bindung an die gallensaeuren faehigen nicht toxischen aktivierten anionenaustauscherharzen mit 2-(4'-(p-chlorbenzoyl)-ph enoxy)-2-(methyl)-propionsaeure und diese salze enthaltende arzneimittel.

Info

Publication number
ATE502T1
ATE502T1 AT79104010T AT79104010T ATE502T1 AT E502 T1 ATE502 T1 AT E502T1 AT 79104010 T AT79104010 T AT 79104010T AT 79104010 T AT79104010 T AT 79104010T AT E502 T1 ATE502 T1 AT E502T1
Authority
AT
Austria
Prior art keywords
salts
group
chlorobenzoyl
resins
acids
Prior art date
Application number
AT79104010T
Other languages
English (en)
Inventor
Valerio Dr. Borzatta
Manlio Dr. Cristofori
Angelo Dr. Brazzi
Original Assignee
Alfa Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici S.P.A. filed Critical Alfa Farmaceutici S.P.A.
Application granted granted Critical
Publication of ATE502T1 publication Critical patent/ATE502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/05—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
    • C08B15/06—Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur containing nitrogen, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT79104010T 1978-12-21 1979-10-17 Salze von zur dauernden bindung an die gallensaeuren faehigen nicht toxischen aktivierten anionenaustauscherharzen mit 2-(4'-(p-chlorbenzoyl)-ph enoxy)-2-(methyl)-propionsaeure und diese salze enthaltende arzneimittel. ATE502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT03631/78A IT1106718B (it) 1978-12-21 1978-12-21 Composizioni a base di resine anioniche salificate farmacologicamente attive
EP79104010A EP0012804B2 (de) 1978-12-21 1979-10-17 Salze eines zur dauernden Bindung an die Gallensäuren fähigen nicht toxischen aktivierten Anionenaustauscherharzes mit 2-(4'-(p-Chlorbenzoyl)-phenoxy)-2-(methyl)-propionsäure und diese Salze enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE502T1 true ATE502T1 (de) 1982-01-15

Family

ID=11110905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104010T ATE502T1 (de) 1978-12-21 1979-10-17 Salze von zur dauernden bindung an die gallensaeuren faehigen nicht toxischen aktivierten anionenaustauscherharzen mit 2-(4'-(p-chlorbenzoyl)-ph enoxy)-2-(methyl)-propionsaeure und diese salze enthaltende arzneimittel.

Country Status (11)

Country Link
US (1) US4340585A (de)
EP (1) EP0012804B2 (de)
JP (1) JPS55115403A (de)
AT (1) ATE502T1 (de)
DE (1) DE2961714D1 (de)
DK (1) DK159660C (de)
ES (1) ES487019A1 (de)
GR (1) GR72734B (de)
IT (1) IT1106718B (de)
NO (1) NO794225L (de)
YU (1) YU313079A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393145A (en) * 1979-05-01 1983-07-12 Etablissement Texcontor Anionic ion exchange resins with cholesterol-decreasing properties
CH655507B (de) * 1983-01-12 1986-04-30
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4877775A (en) * 1986-06-16 1989-10-31 E. I. Du Pont De Nemours And Company Polymeric aminosaccharides as antihypercholesterolemic agents
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
US5498678A (en) * 1992-12-21 1996-03-12 Rohm And Haas Company Suspension polymerization process for water-soluble monomers
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US5753262A (en) * 1995-06-07 1998-05-19 Aronex Pharmaceuticals, Inc. Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
US6203785B1 (en) * 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
WO2004054568A1 (en) * 2002-12-17 2004-07-01 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
CA2815749C (en) 2010-11-04 2019-12-03 Albireo Ab Ibat inhibitors for the treatment of liver diseases
SG190433A1 (en) 2010-11-08 2013-06-28 Albireo Ab A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
PT2771003T (pt) 2011-10-28 2017-07-26 Lumena Pharmaceuticals Llc Inibidores da reciclagem de ácidos biliares para tratamento de doenças hepáticas colestáticas pediátricas
EP2770990A4 (de) 2011-10-28 2015-03-11 Lumena Pharmaceuticals Inc Gallensäurerückflusshemmer zur behandlung von hypercholämie und cholestatischer lebererkrankung
AU2014228850A1 (en) 2013-03-15 2015-10-29 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
MX2015013196A (es) 2013-03-15 2016-04-15 Lumena Pharmaceuticals Inc Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett.
WO2020167964A1 (en) 2019-02-12 2020-08-20 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
BE580490A (fr) 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
FR4933M (de) * 1964-09-17 1967-03-28
NL7017227A (de) 1969-12-27 1971-06-29
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4027009A (en) 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol

Also Published As

Publication number Publication date
US4340585A (en) 1982-07-20
EP0012804B1 (de) 1981-12-30
DE2961714D1 (en) 1982-02-18
DK159660C (da) 1991-04-08
DK159660B (da) 1990-11-12
NO794225L (no) 1980-06-24
IT7803631A0 (it) 1978-12-21
ES487019A1 (es) 1980-10-01
EP0012804A1 (de) 1980-07-09
GR72734B (de) 1983-12-01
IT1106718B (it) 1985-11-18
JPS6327362B2 (de) 1988-06-02
EP0012804B2 (de) 1987-03-04
YU313079A (en) 1983-02-28
JPS55115403A (en) 1980-09-05
DK548279A (da) 1980-06-22

Similar Documents

Publication Publication Date Title
ATE502T1 (de) Salze von zur dauernden bindung an die gallensaeuren faehigen nicht toxischen aktivierten anionenaustauscherharzen mit 2-(4'-(p-chlorbenzoyl)-ph enoxy)-2-(methyl)-propionsaeure und diese salze enthaltende arzneimittel.
GB2255339A (en) Peptidyl derivatives
ATE205508T1 (de) Vernetzte polymere enthaltende zusammensetzung zum entfernen von gallensäuren bei patienten
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
ES8604545A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ATE25078T1 (de) 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
PT69823A (de) 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saureadditionssalze diese enthaltene arzneimittel und verfahrenzu deren herstellung
SE8205698L (sv) N-(4-(3-aminopropyl)aminobutyl-2-(omega-guanidinofettsyra-amido)-2-substituerad-etanamid, salt derav och forfarande for framstellning derav
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
DK154501C (da) 5-amino-2,4,6-trijodisophthalsyre-bis-amid-derivater og deres salte med roentgenkontrastsyrer
ES543786A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
DE3761560D1 (de) Substituierte derivate von n-aethyl(meth)acrylamid, und verfahren zu ihrer herstellung.
DK67384D0 (da) N-iminopyridiniumbetainderivater
ES488387A1 (es) Procedimiento de preparacion de derivados condensados de pi-rrolidina
ZA84571B (en) Compounds derived from amides of mercaptoacetic acid and from 3-mercaptopropionic acid and pharmaceutical compositions containing them
SE8200309L (sv) Guanidinocyklohexankarboxylsyraderivat
ATE120179T1 (de) Verfahren zum herstellen von alpha-fluorierten acrylaten.
GB1447911A (en) Process for producing polyamines
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
GB1477937A (en) Aminals of aromatic aldehydes
BG50993A1 (en) 2, 3, 5- three substituted oxazolydines and process for their preparation
ATE60048T1 (de) Aminoverbindungen und diese enthaltende fungizide.
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.
ES375495A1 (es) Procedimiento para la preparacion de vetonas derivadas de la 1-(2-hidroxi-etil) piperazina.
ES8500885A1 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee